1. Home
  2. KSCP vs ICCC Comparison

KSCP vs ICCC Comparison

Compare KSCP & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$3.00

Market Cap

58.1M

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$8.40

Market Cap

64.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSCP
ICCC
Founded
2013
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
64.0M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
KSCP
ICCC
Price
$3.00
$8.40
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
465.6K
28.8K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
63.54
53.85
EPS
N/A
N/A
Revenue
$11,335,000.00
$26,493,169.00
Revenue This Year
$218.66
N/A
Revenue Next Year
$54.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.91
51.64
52 Week Low
$2.92
$4.52
52 Week High
$10.13
$9.08

Technical Indicators

Market Signals
Indicator
KSCP
ICCC
Relative Strength Index (RSI) 38.22 58.91
Support Level $2.96 $5.78
Resistance Level $4.43 N/A
Average True Range (ATR) 0.17 0.30
MACD 0.01 -0.03
Stochastic Oscillator 9.26 42.75

Price Performance

Historical Comparison
KSCP
ICCC

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: